Nature
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Nature
Jul 24, 2024, 02:33 |
Insight
Hope in CAR-T Therapy: Promising Results in Incurable Pediatric Brain Cancer
Hung Trinh, Senior Director of Business Development at OBiO Tech, shared a post on LinkedIn…
Jul 23, 2024, 08:25 |
Blog
Paolo Tarantino: HER2: a remarkable story of precision oncology
Paolo Tarantino shared on X: "HER2: a remarkable story of precision oncology. Check this wonderful Nature…
Jul 15, 2024, 11:19 |
Insight
Piotr Wysocki: Does getting old decrease the risk of being diagnosed with lung cancer?
Piotr Wysocki recently posted on LinkedIn: “An intriguing article by Heidi Ledford has recently been published…
Jul 11, 2024, 14:39 |
Insight
Tejas Patil: DeepPT predicts tumor mRNA expression from hematoxylin and eosin slides
Tejas Patil, Thoracic oncologist at University of Colorado Cancer Center, shared a paper by Danh-Tai…
Jul 5, 2024, 10:00 |
Blog
Mansoor Raza Mirza: I am looking forward to our collaboration with Qinglei Gao and her team
Mansoor Raza Mirza, Chief Oncologist at the Department of Oncology, Rigshopitalet, shared on Facebook: "An…
Jun 30, 2024, 05:23 |
Blog
María Mayán: How and why becoming an editor
María Mayán, Research Group Leader at CINBIO, shared on X/Twitter: . "Lunch session with editors:…
Jun 14, 2024, 05:23 |
Insight
Douglas Flora: Mika Newton and xCures share how AI tools can help improve cancer patients mental health
Douglas Flora shared a post by xCures on LinkedIn, adding: “Thanks, Mika Newton and xCures, for…
Jun 13, 2024, 17:33 |
Insight
Agenus' Phase 1 clinical trial results have been published in Nature
Agenus shared their publication on investigational immunotherapeutic agents in Nature: "Results from our Phase 1…
Jun 13, 2024, 05:48 |
Blog
Rabab Hunaid Abbas: An exclusive keynote event with Dr. Thomas Marron
Rabab Hunaid Abbas, Member at Georgian International Medical Student Society, shared a post on LinkedIn: "Upcoming…
Jun 1, 2024, 23:36 |
Blog
Paolo Tarantino: Our article on Optimizing the Safety of ADCs for their Outlook on Cancer treatment has been published in Nature
Paolo Tarantino shared a post on LinkedIn: ''Grateful to Nature for selecting our article on…
May 29, 2024, 08:36 |
Insight
A new review summarizing the different antibody-based approaches for targeting cancer cells - Nature Reviews Cancer
Nature Reviews Cancer shared a post on X: "Don´t miss this review summarizing the different…
May 21, 2024, 12:45 |
Insight
Enrique Grande: Improving antitumor immune response via Treg reduction in bladder cancer
Enrique Grande, Head of the Medical Oncology Service and Director of Clinical Research at the MD…
May 9, 2024, 11:00 |
Insight
Vivek Subbiah: AlphaFold 3 is beyond amazing!
Vivek Subbiah shared on X: “Wow! Just when we thought Alphafold 1,2 are groundbreaking, it’s…
May 9, 2024, 10:01 |
Insight
Lewis Cantley: The Tyrosine Kinase Library, now in Nature
Lewis Cantley, Professor of Cell Biology at Harvard Medical School, shared a thread on X:…
May 6, 2024, 11:38 |
Insight
Ashley Kiemen: The anatomic and genomic properties of pancreatic cancer precursors
Ashley Kiemen, Assistant Professor in Pathology at the Johns Hopkins University, shared on X: "I’m…
May 5, 2024, 06:53 |
Blog
Cancer Grand Challenges team Mutographs in Nature
Cancer Grand Challenges shared on their X/Twitter: ''Congratulation Cancer Grand Challenges team Mutographs on their…
Apr 27, 2024, 12:57 |
Blog
Matteo Morotti: The results of our study on the effect of prostaglandin E2 on T cells
Matteo Morotti, Medical program leader at CDR-Life, shared on X/Twitter: "Proud to share the results…
Apr 22, 2024, 17:35 |
Insight
Peggy Goodell: We are all walking mosaics of genetically distinct cells
Peggy Goodell, Professor and Chair of the Department of Molecular Cell Biology at Baylor College…
Apr 17, 2024, 18:37 |
Blog
Piotr Wysocki: A new, broad-spectrum RAS-GTP inhibitor holds promise in pancreatic cancer
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 15, 2024, 02:29 |
Insight
Evan Weber: Transcription factors that drive beneficial memory programs in CAR T cells
Evan Weber, Assistant Professor of Pediatrics at the University of Pennsylvania Perelman School of Medicine,…
Mar 23, 2024, 04:57 |
Insight
Alicia Perzolli: Happy to share my first publication for my Ph.D. at Princess Máxima Center for Pediatric Oncology about 'Targeting the innate immune system in pediatric and adult AML'
Mar 5, 2024, 14:37 |
Blog
Paolo Tarantino: Interesting read on many recent deals in the ADC field
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Feb 12, 2024, 16:50 |
Blog
Magdalena Skipper: Applications are open for the 2024 Nature Award for Inspiring Women in Science
Magdalena Skipper, Editor in Chief at Nature, made the following post on X: "Applications are…
Jan 15, 2024, 13:28 |
Insight
Shubham Pant: Phase 1 AMPLIFY-201 trial
Shubham Pant, Professor, Department of Gastrointestinal (GI) Medical Oncology and Investigational Cancer Therapeutics, Division of…
Dec 19, 2023, 18:44 |
Insight
Paolo Tarantino: Analysis of 20M res articles and 4M patent applications
Paolo Tarantino, Clinical Research Fellow at the Dana-Farber Cancer Institute, shared a post on X/Twitter:…
Dec 19, 2023, 09:13 |
Blog
Yüksel Ürün: Congratulations to Tom Powles for being recognized as one of the top influencers in science for the year 2023 by Nature!
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Dec 14, 2023, 16:12 |
Insight
Mohammad Shahrokh Esfahani: We aimed to study classic Hodgkin lymphoma using various noninvasive techniques applied to plasma ctDNA
Mohammad Shahrokh Esfahani, Instructor in Oncology at Stanford University, shared a LinkedIn post by Stanford…
Nov 4, 2023, 22:51 |
Blog
Nature's Take: How will ChatGPT and generative AI transform research?
Nature, made the following post on Twitter: "Nature's Take: How will ChatGPT and generative AI transform…
Oct 31, 2023, 15:43 |
Career
Andres Moreno-Estrada: First time I get the cover of a magazine and it's in Nature!
Andres Moreno-Estrada, Professor and Head of the Genome Core Facility (LANGEBIO) Employment, shared Twitter: "First…
Oct 8, 2023, 18:09 |
Stories
Mushtaq Bilal: Once you put your work out without caring about prestige, two good things happen.
Quoting Mushtaq Bilal on X/Twitter: ''Nature rejected her paper for not being original, University of…
Oct 7, 2023, 19:42 |
Blog
Najat Khan: The results of the world’s largest blood biomarker study have been published in Nature, opening up new possibilities for scientific research.
Najat Khan, Chief Data Science Officer & SVP/Global Head, Strategy, Portfolio, Ops, R&D, J&J at…
Sep 9, 2023, 08:15 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 3
On August 26th, which marks Women's Equality Day in the United States, OncoDaily began featuring…
Sep 8, 2023, 19:03 |
Insight
Angela Mastronuzzi: Our Ospedale Pediatrico Bambino Gesù team's recently published paper with Nature Communications by Nature Portfolio is out.
Angela Mastronuzzi, Head of Neuro-Oncology Unit at Bambino Gesù Children's Hospital, recently posted on LinkedIn:…
Aug 6, 2023, 17:50 |
Blog
5 years is a VERY LONG time for a paper to be under review, That was the case for our recently published paper in Nature - Segun Fatumo
5 years is a VERY LONG time for a paper to be under review. That…
All:
34
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube